Drug Patents owned by Purdue Pharma
1. Drug name - INTERMEZZO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7682628 | PURDUE PHARMA | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
Feb, 2025
(2 years from now) | |
| US8252809 | PURDUE PHARMA | Compositions for treating insomnia |
Feb, 2025
(2 years from now) | |
| US7658945 | PURDUE PHARMA | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
Apr, 2027
(4 years from now) | |
| US8242131 | PURDUE PHARMA | Methods of treating middle-of-the-night insomnia |
Aug, 2029
(6 years from now) | |
Drugs and Companies using ZOLPIDEM TARTRATE ingredient
Treatment: Method for treating insomnia; Method of treating middle-of-the-night insomnia
Dosage: TABLET;SUBLINGUAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1.75MG | TABLET;SUBLINGUAL | Discontinued |
| 3.5MG | TABLET;SUBLINGUAL | Discontinued |
2. Drug name - RYZOLT
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7988998 | PURDUE PHARMA | Sustained-release tramadol formulations with 24-hour efficacy |
Oct, 2023
(1 year, 29 days from now) | |
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 100MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 200MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 300MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.